Is it safe?
Can GILD take a bad year?
The deepest fall in GILD's price history on file is −30%; it is −3.8% below its high today.
$23.1B
Net debt · as at Q2 2026 · debt less the cash on hand
- Altman Z-score
- 4.08
Altman Z-score · safe zone, above 3
- Interest cover
- none
Interest cover · no operating profit to pay the interest bill from
- Annualised volatility
- 27%
Annualised volatility · about as steady as the market itself
Details›
- Total debtQ2 2026
- $26.2B
- Cash and short-term investments
- $3.18B
- Net debt
- $23.1B
- EBITDA, trailing twelve months
- −$2.13B
- Operating profit, trailing twelve months
- −$2.50B
- Debt / equity
- 2.22×
- Annualised volatilitytwo years of daily moves
- 27%
- Worst drawdown on file
- −30%
- Below its 52-week high
- −3.8%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Drug Manufacturers - General
Ranks #6 of 16 by Smart Score